| Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands K Nishimoto, SA Tomlins, R Kuick, AK Cani, TJ Giordano, DH Hovelson, ... Proceedings of the National Academy of Sciences 112 (33), E4591-E4599, 2015 | 305 | 2015 |
| Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors DH Hovelson, AS McDaniel, AK Cani, B Johnson, K Rhodes, PD Williams, ... Neoplasia 17 (4), 385-399, 2015 | 220 | 2015 |
| Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes TumorsNext-Generation Sequencing of Phyllodes Tumors AK Cani, DH Hovelson, AS McDaniel, S Sadis, MJ Haller, V Yadati, ... Molecular Cancer Research 13 (4), 613-619, 2015 | 139 | 2015 |
| Next-generation sequencing of tubal intraepithelial carcinomas AS McDaniel, JN Stall, DH Hovelson, AK Cani, CJ Liu, SA Tomlins, ... JAMA oncology 1 (8), 1128-1132, 2015 | 126 | 2015 |
| Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma SC Smith, K Trpkov, YB Chen, R Mehra, D Sirohi, C Ohe, AK Cani, ... The American journal of surgical pathology 40 (11), 1457, 2016 | 125 | 2016 |
| Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy AS McDaniel, DH Hovelson, AK Cani, CJ Liu, Y Zhai, Y Zhang, AZ Weizer, ... Cancer research 75 (24), 5219-5227, 2015 | 111 | 2015 |
| Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance MechanismsCTC Genomic Profiling in … C Paoletti, AK Cani, JM Larios, DH Hovelson, K Aung, EP Darga, ... Cancer research 78 (4), 1110-1122, 2018 | 102 | 2018 |
| Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation PW Harms, AMB Collie, DH Hovelson, AK Cani, ME Verhaegen, RM Patel, ... Modern Pathology 29 (3), 240-248, 2016 | 94 | 2016 |
| A distinctive, low‐grade oncocytic fumarate hydratase‐deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase‐deficient renal cell carcinoma SC Smith, D Sirohi, C Ohe, JB McHugh, JL Hornick, J Kalariya, S Karia, ... Histopathology 71 (1), 42-52, 2017 | 86 | 2017 |
| Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies AK Cani, DH Hovelson, H Demirci, MW Johnson, SA Tomlins, RC Rao Oncotarget 8 (5), 7989, 2017 | 79 | 2017 |
| Intra-tumor genetic heterogeneity in rectal cancer KM Hardiman, PJ Ulintz, RD Kuick, DH Hovelson, CM Gates, A Bhasi, ... Laboratory Investigation 96 (1), 4-15, 2016 | 78 | 2016 |
| Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies AK Cani, M Soliman, DH Hovelson, CJ Liu, AS McDaniel, MJ Haller, ... Modern pathology 29 (7), 685-697, 2016 | 62 | 2016 |
| Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma JI Warrick, DH Hovelson, A Amin, CJ Liu, AK Cani, AS McDaniel, V Yadati, ... Virchows Archiv 466, 297-311, 2015 | 58 | 2015 |
| Integrative molecular profiling of routine clinical prostate cancer specimens CS Grasso, AK Cani, DH Hovelson, MJ Quist, NJ Douville, V Yadati, ... Annals of Oncology 26 (6), 1110-1118, 2015 | 47 | 2015 |
| Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations PW Harms, DH Hovelson, AK Cani, K Omata, MJ Haller, ML Wang, D Arps, ... Human pathology 51, 25-31, 2016 | 45 | 2016 |
| Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable FGFR3 Amplifications LL de la Vega, JB McHugh, AK Cani, K Kunder, FM Walocko, CJ Liu, ... Molecular Cancer Research 15 (11), 1551-1557, 2017 | 39 | 2017 |
| Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low‐risk patient as defined by targeted sequencing BN Tillman, M Yanik, AC Birkeland, CJ Liu, DH Hovelson, AK Cani, ... Head & neck 38 (S1), E1646-E1652, 2016 | 37 | 2016 |
| Molecular profiling to determine clonality of serial magnetic resonance imaging/ultrasound fusion biopsies from men on active surveillance for low-risk prostate cancer GS Palapattu, SS Salami, AK Cani, DH Hovelson, L Lazo de la Vega, ... Clinical Cancer Research 23 (4), 985-991, 2017 | 28 | 2017 |
| Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment KC Kadakia, SA Tomlins, SK Sanghvi, AK Cani, K Omata, DH Hovelson, ... Journal of hematology & oncology 8, 1-7, 2015 | 26 | 2015 |
| Molecular profiling of multiple primary Merkel cell carcinoma to distinguish genetically distinct tumors from clonally related metastases KL Harms, LL de la Vega, DH Hovelson, S Rahrig, AK Cani, CJ Liu, ... JAMA dermatology 153 (6), 505-512, 2017 | 22 | 2017 |
